{"description":"Information about adverse effects associated with blood transfusions were collected, only for participants in Arm A (Intervention Arm). Adverse events in the \"Caregiver\" arm were not collected.","eventGroups":[{"deathsNumAffected":10,"deathsNumAtRisk":10,"description":"Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment.\n\nTransfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care","id":"EG000","otherNumAffected":0,"otherNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"title":"Intervention Arm"}],"frequencyThreshold":"0","timeFrame":"From the date of study enrollment until the date of death."}